UMSS20 Student Profile: Jacob Cote

UMaine Alert

Posted: April 19, 2024 - 1:32 PM

At approximately 9:24 a.m. on Friday, April 19, a University of Maine graduate student was struck by a university vehicle on Long Road at the University of Maine campus in Orono. The student reports that they are at a local hospital with minor injuries.

Emergency services, including the Orono Fire Department, University Volunteer Ambulance Corps, University of Maine Police Department, Orono Police Department and Penobscot County Sheriff’s Office responded to the scene.

The university vehicle involved in the incident was a Chevrolet Express van. It was being operated by a university employee.

Counseling services and support are available for students, faculty or staff who may have been affected. The Counseling Center can be reached at 207-581-1392 and the Dean of Students Office can be reached at 207-581-1406.

The scene has been cleared and Long Road is now accessible. An investigation is being conducted by the University of Maine Police Department with assistance from the Penobscot County Sheriff’s Office Crash Reconstruction Unit. Any witnesses to the incident are encouraged to contact Lt. Noel Santiago at noel.santiago@maine.edu.

March 1, 2020 UMSS Student Profiles 2020

Jacob Cote, Microbiology
The Role of Prophage in Mycobacterial Antibiotic Resistance
Mentored by Sally Molloy

Jacob Cote is studying bacteriophage (bacterial viruses) in order to better understand antibiotic resistance and bacterial fitness. Bacteriophage are major contributors to the severity of diseases such as cholera and pathogenic E. coli. Cote’s goal is to better understand bacteriophage, so that he can help combat bacteriophage-mediated infections as well as difficult-to-treat bacterial infections caused by antibiotic resistance in which bacteriophage can play a role.

“Understanding how bacteriophage are influencing antibiotic resistance in bacteria could potentially allow us to turn back the clock on some of these diseases, and make currently hard to treat diseases like Tuberculosis much more accessible to those around the world,” says Cote.